CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) was the recipient of a large decrease in short interest in the month of April. As of April 30th, there was short interest totaling 19,064 shares, a decrease of 39.2% from the April 15th total of 31,352 shares. Based on an average daily volume of 140,854 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are short sold.
Analyst Ratings Changes
A number of analysts have weighed in on CHEOY shares. Zacks Research raised shares of CochLear to a “hold” rating in a report on Friday, April 17th. UBS Group downgraded shares of CochLear from a “strong-buy” rating to a “hold” rating in a report on Thursday, April 23rd. Finally, Royal Bank Of Canada raised shares of CochLear from a “hold” rating to a “moderate buy” rating in a report on Monday, January 19th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, CochLear presently has a consensus rating of “Moderate Buy”.
Check Out Our Latest Research Report on CHEOY
CochLear Stock Down 0.6%
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Further Reading
- Five stocks we like better than CochLear
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
